Developer docs
API playgroundTry for free, no card

Search company profiles

RxLogix Corporation

Full company profile

uuid0007pky

Namestring
RxLogix Corporation
Legal namestring
RxLogix Corporation
Websiteurl
rxlogix.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

RxLogix Corporation is a private pharmacovigilance (PV) and risk management software company founded in 2010, headquartered in Aventura, Florida, with 51-100 employees distributed across offices in the US (Princeton, Irvine), UK (Chadwell Heath), Germany (Lörrach), India (Noida, Bengaluru), and Japan (Tokyo). The company builds a cloud-native, AI-enabled SaaS platform that serves pharmaceutical manufacturers and global regulatory agencies — most notably the US FDA, where its FAERS II system has been live since 2021-11 processing 25M+ cases for 2,800+ users, and the European Medicines Agency, where its pan-European Substance Management System went live in 2025-12 covering 35M+ reports.

The core product is a modular PV platform covering the full safety lifecycle — case management, signal detection, aggregate and periodic reporting (PSUR/PBRER/IND/NDA), publishing, risk management, quality, gateways, data hub, clinical safety, and analytics — delivered as subscription SaaS on AWS with GxP, 21 CFR Part 11, ISO 27001, SOC 2 Type II, HIPAA, GDPR, and EU-U.S. Data Privacy Framework compliance. In 2026-04 the company launched PVOne.AI, a fourth-generation agentic AI layer that applies NLP, autonomous agents, anomaly detection, predictive analytics, and recommendation engines to automate case processing and decisioning. The company also sells Safety-in-a-Box, a bundled mid-market offering at a flat yearly fee, and extends into adjacent regulated verticals including vaccines, combination products, and medical devices.

Commercially, RxLogix operates a subscription-based enterprise SaaS model with multi-year contracts, professional services for implementation and validation, and managed services for ongoing safety operations. Named customers include the FDA, EMA, Moderna, Incyte, Organon, ProPharma, and Nobel Biocare, alongside other Top 20 pharma accounts; the company also works through PV BPO and implementation partners to extend reach. No external funding rounds are publicly disclosed, indicating growth has been funded by operating cash flow. Leadership is founder-led: Raj More serves as CEO and Chief Architect, Christopher M Lee as COO, Vishal Singh as VP of IT & Security / CISO, and Suranjan De as VP of Client Relations & Product Innovation.

Short descriptiontext

RxLogix is a private pharmacovigilance SaaS company serving global regulators and pharma — its PV platform powers FDA's FAERS II and EMA's substance management system, with a new PVOne.AI agentic AI layer and bundled mid-market Safety-in-a-Box offering.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAventura, United States
HQ citystring
Aventura
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacovigilance software, drug safety platform, adverse event management, signal detection software, regulatory reporting SaaS
Industry4 codes
PRIMARYHLAGALAJ
PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited)
SECONDARYHLAGAKAH
Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDABAHAI
Cloud Compliance, Audit & Continuous Controls Monitoring (CCM/GRC)
Hardware, Technology & Telecom/Cloud & Data Center Infrastructure/Cloud Security & Compliance Infrastructure
NAICS code4 codes
  • Software Publishers5132
  • Software Publishers51321
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Pharmacovigilance Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Platform Licensing
TypeSubscription Recurring
Description

Subscription-based SaaS licensing of the PV platform and individual modules (PV Case Management, PV Signal, PV Reports, PV Publisher, PV Central, PV Quality, PV Risk Manager). Multi-tenant cloud architecture with annual or multi-year contract terms.

rxlogix.com:443
2Professional Services
TypeProfessional Services
Description

Implementation services including Rapid PV Systems Implementation, PV Strategy with AI, Analytics and Reporting Services, Education and Training, and Global PV BPO services.

rxlogix.com:443
3Managed Services
TypeManaged Services
Description

Ongoing managed services and operational support including cloud hosting, 24/7 support desk, inspection support, and continuous compliance monitoring.

rxlogix.com:443
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details2 tiers
1Safety-in-a-Box (SIAB) - Complete end-to-end PV platform bundle
ModelSubscriptionBilling cadenceAnnual
Notes

One flat yearly fee; all-inclusive solution with full platform capabilities deployed within 12 weeks; includes managed services and support

rxlogix.com:443
2Modular platform with individual product licensing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Individual modules: PV Case Management, PV Signal, PV Reports, PV Publisher, PV Central, PV Quality, PV Risk Manager; pricing varies by module and volume

rxlogix.com:443
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Safety-In-A-Box
Description

Cloud-native, AI-powered pharmacovigilance platform that unifies the full PV lifecycle into a single scalable ecosystem

rxlogix.com:443
+2 more records
Core offering1 text field

RxLogix builds and sells a unified, cloud-native pharmacovigilance (PV) SaaS AI Platform and related individual modules (PV Case Management, PV Signal, PV Reports, PV Publisher, PV Risk Manager, PV Central, PV Quality) for case intake and processing, signal detection, regulatory reporting, and compliance monitoring across the drug-safety lifecycle. Revenue is generated through subscription licensing of the platform and modules, complemented by professional services (Rapid PV Systems Implementation, PV Strategy, Analytics, Education, Global PV BPO) and managed services for cloud hosting, support, and inspection readiness.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 60-80% fewer manual touchpoints in case processing
+8 more records
Product overview1 text field

RxLogix offers a unified PV SaaS AI Platform architecture comprising integrated modules for the complete pharmacovigilance lifecycle. The core products include PV Case Management for intake and case processing (achieving 60-80% efficiency gains), PV Signal for signal detection and management (2-3x faster detection), PV Reports for regulatory and ad-hoc reporting, PV Publisher for document authoring (50%+ timeline reduction), and PV Risk Manager for risk oversight. Additional modules include PV Central (compliance monitoring), PV Quality (quality tracking), PV Gateway (automated submissions), PV DataHub (data integration), PV Clinical (clinical trial PV), and PV Analytics (predictive insights). Safety-In-A-Box packages the core platform capabilities into a simplified, faster-to-implement solution. All products share a single governed data model, automated application layer, and unified AI capabilities powered by domain-trained models including the fourth-generation PVOne.AI agentic AI.

Product and service12 records
1PV SaaS AI Platform
CategoryPharmacovigilance platform
Description

Unified cloud-native pharmacovigilance platform powered by AI that covers the full safety lifecycle (case intake through regulatory submission) with a single governed data model, automated application layer, and one source of truth for all PV operations.

2Safety-In-A-Box
CategoryBundled PV offering
Description

Complete end-to-end PV solution that consolidates the full pharmacovigilance lifecycle into a single, scalable ecosystem with 50-70% faster implementation timelines, 30-50% lower infrastructure costs, and 99.9%+ platform availability for mid-market and emerging pharma/biotech.

3PV Case Management
CategoryCase management module
Description

AI-powered adverse event processing and case intake solution that automates global case intake, follow-up, triage, processing, and reporting with medical coding against MedDRA and WHO-DD standards.

4PV Reports
CategoryReporting and analytics module
Description

Self-service regulatory reporting and analytics tool supporting canned and ad-hoc reports with out-of-the-box visualizations, automated report generation, and integrated Spotfire analytics.

5PV Signal
CategorySignal detection module
Description

Signal detection and management platform providing dynamic data mining and Bayesian analytics for detecting signals, uncovering patterns, and recognizing emerging trends in adverse event report data; detects signals 2-3x faster with 40-60% fewer false positives.

6PV Publisher
CategoryDocument authoring module
Description

Global regulatory submission and document authoring solution that automates content creation for PBRERs, DSURs, PSMFs, and PV Agreements with AI-assisted automation from plan to publish.

7PV Risk Manager
CategoryRisk management module
Description

Risk identification and management solution integrated into the unified PV platform for detecting and investigating emerging safety signals with risk oversight capabilities.

8PV Central
CategoryCompliance monitoring module
Description

Compliance monitoring and data harmonization solution that unifies PV business operations, enables intelligent workflows, and delivers real-time actionable insights for compliance oversight.

9PV Quality
CategoryQuality monitoring module
Description

Quality monitoring solution for global regulatory compliance with embedded quality checks, CAPA tracking, and issue resolution capabilities for inspection readiness.

10PVOne.AI
CategoryAgentic AI platform
Description

Fourth-generation agentic AI solution providing intelligent orchestration across end-to-end safety operations; domain-trained models deliver up to 80% reduction in manual effort, 75% higher reviewer productivity, and up to 50% touchless workflows with human-in-the-loop controls.

11Rapid PV Systems Implementation
CategoryProfessional services
Description

Implementation service to rapidly stand up the RxLogix PV platform for enterprise and mid-market customers, supporting faster timelines versus legacy deployments.

12Managed Services and Operational Support
CategoryManaged services
Description

Ongoing managed services and operational support including cloud hosting, 24/7 support desk, inspection support, and continuous compliance monitoring for customers running the PV platform.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-29
Description

Strategic software agreement with EMA to develop the new Signal and Safety Analytics (SSA) platform including RxLogix PV Signal, PV Reports, and PV Analytics. The platform supports signal detection and validation activities for the European Medicines Regulatory Network (EMRN) across 35M+ safety reports.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2018-11-19
Description

Booz Allen Hamilton supported the implementation of RxLogix PV Signal and PV Reports at the U.S. FDA as part of the FAERS modernization effort. This was a critical implementation partnership for the landmark FDA contract.

Strategic tierCoreTypeTechnology or Integration
Description

Cloud infrastructure provider for RxLogix's multi-tenant SaaS platform. AWS-based hosting provides scalability, reliability, and performance for enterprise PV deployments.

4Eisai
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Guest speaker collaboration at RxLogix PV Digital Transformation Seminar Series 2024-Tokyo. E. Stewart Geary, MD, Global Safety Officer at Eisai presented on CIOMS XII Structured Benefit Risk Framework.

rxlogix.com:443
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Guest speaker collaboration at RxLogix PV Digital Transformation Seminar Series 2024-Tokyo. Ken Kubota, SVP PV Operations at Astellas participated as industry speaker.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Guest speaker collaboration at RxLogix PV Digital Transformation Seminar Series 2024-Tokyo. Jens Nordahl, Senior Project Manager at Lundbeck participated as industry speaker.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parexel is a global CRO with significant pharmacovigilance service offerings. As a CRO-led PV service provider, it competes with RxLogix's PV BPO partners and managed services for outsourced safety operations at large pharma and biotech.

TypeEmerging player
Description

AB Cube specializes in E2B safety reporting and pharmacovigilance data exchange tools. It competes with RxLogix's PV Gateway and E2B/ICSR submission capabilities, often as a complementary tool or alternative for safety reporting workflows.

TypeBroad incumbent
Description

IQVIA offers safety/pharmacovigilance technology alongside its dominant CRO services and real-world evidence platforms. RxLogix is named alongside IQVIA as a leading vendor in ResearchAndMarkets.com PV market reports, and IQVIA represents a broad incumbent that competes for both PV software and PV BPO spend.

TypeDirect peer
Description

Sarjen Systems provides pharmacovigilance software including case processing and reporting solutions to mid-size pharma. It competes with RxLogix for mid-market PV deals, particularly against Safety-in-a-Box.

TypeEmerging player
Description

EXTEDO provides regulatory information management and pharmacovigilance/safety reporting software. It overlaps with RxLogix in regulatory submission and safety reporting modules, particularly for European mid-market customers.

TypeDirect peer
Description

ArisGlobal's LifeSphere Safety and MVPS platforms are among the most direct competitors to RxLogix's PV platform, covering case intake, signal management, and regulatory reporting. RxLogix explicitly supports interoperability and migration from ArisGlobal, and both vendors target top-20 pharma and mid-market PV modernization.

TypeDirect peer
Description

Veeva Vault Safety is a cloud-native pharmacovigilance application within Veeva's broader life sciences commercial/clinical cloud. Veeva is a direct PV platform peer and a broader life sciences CRM/regulatory incumbent that competes with RxLogix for IT budget allocation in top pharma.

TypeBroad incumbent
Description

Cognizant provides pharmacovigilance BPO and technology services at scale to large pharma. It competes with RxLogix's Global PV BPO partner channel and full PV platform stack, particularly for outsourced case processing and signal management.

TypeDirect peer
Description

Oracle Argus Safety is the incumbent market leader in pharmacovigilance safety databases used by most large pharma. RxLogix's PV Case Management, PV Signal, and PV Reports modules directly compete against Argus Safety's case processing, signal detection, and reporting capabilities, and RxLogix's platform explicitly supports migration from Argus.

TypeEmerging player
Description

Ennov offers a unified regulatory, quality, and pharmacovigilance platform targeted at mid-market life sciences companies. It competes with RxLogix in safety case management and regulatory reporting for smaller and mid-sized pharma and biotech.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration11 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RxLogix Corporation

Pharmacovigilance Softwarerxlogix.com

RxLogix is a private pharmacovigilance SaaS company serving global regulators and pharma — its PV platform powers FDA's FAERS II and EMA's substance management system, with a new PVOne.AI agentic AI layer and bundled mid-market Safety-in-a-Box offering.

What RxLogix Corporation does

RxLogix Corporation is a private pharmacovigilance (PV) and risk management software company founded in 2010, headquartered in Aventura, Florida, with 51-100 employees distributed across offices in the US (Princeton, Irvine), UK (Chadwell Heath), Germany (Lörrach), India (Noida, Bengaluru), and Japan (Tokyo). The company builds a cloud-native, AI-enabled SaaS platform that serves pharmaceutical manufacturers and global regulatory agencies — most notably the US FDA, where its FAERS II system has been live since 2021-11 processing 25M+ cases for 2,800+ users, and the European Medicines Agency, where its pan-European Substance Management System went live in 2025-12 covering 35M+ reports.

The core product is a modular PV platform covering the full safety lifecycle — case management, signal detection, aggregate and periodic reporting (PSUR/PBRER/IND/NDA), publishing, risk management, quality, gateways, data hub, clinical safety, and analytics — delivered as subscription SaaS on AWS with GxP, 21 CFR Part 11, ISO 27001, SOC 2 Type II, HIPAA, GDPR, and EU-U.S. Data Privacy Framework compliance. In 2026-04 the company launched PVOne.AI, a fourth-generation agentic AI layer that applies NLP, autonomous agents, anomaly detection, predictive analytics, and recommendation engines to automate case processing and decisioning. The company also sells Safety-in-a-Box, a bundled mid-market offering at a flat yearly fee, and extends into adjacent regulated verticals including vaccines, combination products, and medical devices.

Commercially, RxLogix operates a subscription-based enterprise SaaS model with multi-year contracts, professional services for implementation and validation, and managed services for ongoing safety operations. Named customers include the FDA, EMA, Moderna, Incyte, Organon, ProPharma, and Nobel Biocare, alongside other Top 20 pharma accounts; the company also works through PV BPO and implementation partners to extend reach. No external funding rounds are publicly disclosed, indicating growth has been funded by operating cash flow. Leadership is founder-led: Raj More serves as CEO and Chief Architect, Christopher M Lee as COO, Vishal Singh as VP of IT & Security / CISO, and Suranjan De as VP of Client Relations & Product Innovation.

RxLogix Corporation firmographics

Firmographics
Name
RxLogix Corporation
Legal name
RxLogix Corporation
Website
https://rxlogix.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
251–500 employees
Short description
RxLogix is a private pharmacovigilance SaaS company serving global regulators and pharma — its PV platform powers FDA's FAERS II and EMA's substance management system, with a new PVOne.AI agentic AI layer and bundled mid-market Safety-in-a-Box offering.
Ownership category
akta.pro rank

RxLogix Corporation industry classification

Industry
Product category
Pharmacovigilance Software
NAICS
Software Publishers (5132), Software Publishers (51321), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGALAJ
PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited)
SECONDARYHLAGAKAH
Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDABAHAI
Cloud Compliance, Audit & Continuous Controls Monitoring (CCM/GRC)
Hardware, Technology & Telecom/Cloud & Data Center Infrastructure/Cloud Security & Compliance Infrastructure

Keywords

  • Pharmacovigilance software
  • Drug safety platform
  • Adverse event management
  • Signal detection software
  • Regulatory reporting SaaS

Where RxLogix Corporation is headquartered

Location

Headquarters

HQ city
Aventura
HQ country
United States
HQ region
North America

Offices8 records

Markets served

RxLogix Corporation business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS Platform Licensing: Subscription-based SaaS licensing of the PV platform and individual modules (PV Case Management, PV Signal, PV Reports, PV Publisher, PV Central, PV Quality, PV Risk Manager). Multi-tenant cloud architecture with annual or multi-year contract terms.
  2. Professional Services: Implementation services including Rapid PV Systems Implementation, PV Strategy with AI, Analytics and Reporting Services, Education and Training, and Global PV BPO services.
  3. Managed Services: Ongoing managed services and operational support including cloud hosting, 24/7 support desk, inspection support, and continuous compliance monitoring.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSafety-in-a-Box (SIAB) - Complete end-to-end PV platform bundle
SubscriptionMulti-year contractModular platform with individual product licensing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

RxLogix Corporation product offering

Product offering

Core offering

RxLogix builds and sells a unified, cloud-native pharmacovigilance (PV) SaaS AI Platform and related individual modules (PV Case Management, PV Signal, PV Reports, PV Publisher, PV Risk Manager, PV Central, PV Quality) for case intake and processing, signal detection, regulatory reporting, and compliance monitoring across the drug-safety lifecycle. Revenue is generated through subscription licensing of the platform and modules, complemented by professional services (Rapid PV Systems Implementation, PV Strategy, Analytics, Education, Global PV BPO) and managed services for cloud hosting, support, and inspection readiness.

Product overview

RxLogix offers a unified PV SaaS AI Platform architecture comprising integrated modules for the complete pharmacovigilance lifecycle. The core products include PV Case Management for intake and case processing (achieving 60-80% efficiency gains), PV Signal for signal detection and management (2-3x faster detection), PV Reports for regulatory and ad-hoc reporting, PV Publisher for document authoring (50%+ timeline reduction), and PV Risk Manager for risk oversight. Additional modules include PV Central (compliance monitoring), PV Quality (quality tracking), PV Gateway (automated submissions), PV DataHub (data integration), PV Clinical (clinical trial PV), and PV Analytics (predictive insights). Safety-In-A-Box packages the core platform capabilities into a simplified, faster-to-implement solution. All products share a single governed data model, automated application layer, and unified AI capabilities powered by domain-trained models including the fourth-generation PVOne.AI agentic AI.

Differentiator

Problem solved

Functional benefit

Brands

  • Safety-In-A-Box: Cloud-native, AI-powered pharmacovigilance platform that unifies the full PV lifecycle into a single scalable ecosystem
  • PVOne.AI
  • RxLogix Agentic AI

Products and services

  • PV SaaS AI Platform Unified cloud-native pharmacovigilance platform powered by AI that covers the full safety lifecycle (case intake through regulatory submission) with a single governed data model, automated application layer, and one source of truth for all PV operations.
  • Safety-In-A-Box Complete end-to-end PV solution that consolidates the full pharmacovigilance lifecycle into a single, scalable ecosystem with 50-70% faster implementation timelines, 30-50% lower infrastructure costs, and 99.9%+ platform availability for mid-market and emerging pharma/biotech.
  • PV Case Management AI-powered adverse event processing and case intake solution that automates global case intake, follow-up, triage, processing, and reporting with medical coding against MedDRA and WHO-DD standards.
  • PV Reports Self-service regulatory reporting and analytics tool supporting canned and ad-hoc reports with out-of-the-box visualizations, automated report generation, and integrated Spotfire analytics.
  • PV Signal Signal detection and management platform providing dynamic data mining and Bayesian analytics for detecting signals, uncovering patterns, and recognizing emerging trends in adverse event report data; detects signals 2-3x faster with 40-60% fewer false positives.
  • PV Publisher Global regulatory submission and document authoring solution that automates content creation for PBRERs, DSURs, PSMFs, and PV Agreements with AI-assisted automation from plan to publish.
  • PV Risk Manager Risk identification and management solution integrated into the unified PV platform for detecting and investigating emerging safety signals with risk oversight capabilities.
  • PV Central Compliance monitoring and data harmonization solution that unifies PV business operations, enables intelligent workflows, and delivers real-time actionable insights for compliance oversight.
  • PV Quality Quality monitoring solution for global regulatory compliance with embedded quality checks, CAPA tracking, and issue resolution capabilities for inspection readiness.
  • PVOne.AI Fourth-generation agentic AI solution providing intelligent orchestration across end-to-end safety operations; domain-trained models deliver up to 80% reduction in manual effort, 75% higher reviewer productivity, and up to 50% touchless workflows with human-in-the-loop controls.
  • Rapid PV Systems Implementation Implementation service to rapidly stand up the RxLogix PV platform for enterprise and mid-market customers, supporting faster timelines versus legacy deployments.
  • Managed Services and Operational Support Ongoing managed services and operational support including cloud hosting, 24/7 support desk, inspection support, and continuous compliance monitoring for customers running the PV platform.

Quantifiable outcome

  • 60-80% fewer manual touchpoints in case processing
  • +8 more outcomes

Companies that use RxLogix Corporation

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles4 records

RxLogix Corporation technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability9 records

Feature8 records

RxLogix Corporation partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • European Medicines Agency (EMA)coreStrategic or Co-development Partner · 29 November 2023Strategic software agreement with EMA to develop the new Signal and Safety Analytics (SSA) platform including RxLogix PV Signal, PV Reports, and PV Analytics. The platform supports signal detection and validation activities for the European Medicines Regulatory Network (EMRN) across 35M+ safety reports.
  • Booz Allen HamiltoncoreImplementation/ SI/ Consulting Partner · 19 November 2018Booz Allen Hamilton supported the implementation of RxLogix PV Signal and PV Reports at the U.S. FDA as part of the FAERS modernization effort. This was a critical implementation partnership for the landmark FDA contract.
  • AWS (Amazon Web Services)coreTechnology or IntegrationCloud infrastructure provider for RxLogix's multi-tenant SaaS platform. AWS-based hosting provides scalability, reliability, and performance for enterprise PV deployments.
  • EisaiminorStrategic or Co-development PartnerGuest speaker collaboration at RxLogix PV Digital Transformation Seminar Series 2024-Tokyo. E. Stewart Geary, MD, Global Safety Officer at Eisai presented on CIOMS XII Structured Benefit Risk Framework.
  • Astellas PharmaminorStrategic or Co-development PartnerGuest speaker collaboration at RxLogix PV Digital Transformation Seminar Series 2024-Tokyo. Ken Kubota, SVP PV Operations at Astellas participated as industry speaker.
  • LundbeckminorStrategic or Co-development PartnerGuest speaker collaboration at RxLogix PV Digital Transformation Seminar Series 2024-Tokyo. Jens Nordahl, Senior Project Manager at Lundbeck participated as industry speaker.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

RxLogix Corporation competitors and assessment

Company assessment

Broad incumbents

  • Parexel International: Parexel is a global CRO with significant pharmacovigilance service offerings. As a CRO-led PV service provider, it competes with RxLogix's PV BPO partners and managed services for outsourced safety operations at large pharma and biotech.
  • IQVIA: IQVIA offers safety/pharmacovigilance technology alongside its dominant CRO services and real-world evidence platforms. RxLogix is named alongside IQVIA as a leading vendor in ResearchAndMarkets.com PV market reports, and IQVIA represents a broad incumbent that competes for both PV software and PV BPO spend.
  • Cognizant Life Sciences (PV Services): Cognizant provides pharmacovigilance BPO and technology services at scale to large pharma. It competes with RxLogix's Global PV BPO partner channel and full PV platform stack, particularly for outsourced case processing and signal management.

Emerging players

  • AB Cube: AB Cube specializes in E2B safety reporting and pharmacovigilance data exchange tools. It competes with RxLogix's PV Gateway and E2B/ICSR submission capabilities, often as a complementary tool or alternative for safety reporting workflows.
  • EXTEDO: EXTEDO provides regulatory information management and pharmacovigilance/safety reporting software. It overlaps with RxLogix in regulatory submission and safety reporting modules, particularly for European mid-market customers.
  • Ennov: Ennov offers a unified regulatory, quality, and pharmacovigilance platform targeted at mid-market life sciences companies. It competes with RxLogix in safety case management and regulatory reporting for smaller and mid-sized pharma and biotech.

Direct peers

  • Sarjen Systems: Sarjen Systems provides pharmacovigilance software including case processing and reporting solutions to mid-size pharma. It competes with RxLogix for mid-market PV deals, particularly against Safety-in-a-Box.
  • ArisGlobal: ArisGlobal's LifeSphere Safety and MVPS platforms are among the most direct competitors to RxLogix's PV platform, covering case intake, signal management, and regulatory reporting. RxLogix explicitly supports interoperability and migration from ArisGlobal, and both vendors target top-20 pharma and mid-market PV modernization.
  • Veeva Systems: Veeva Vault Safety is a cloud-native pharmacovigilance application within Veeva's broader life sciences commercial/clinical cloud. Veeva is a direct PV platform peer and a broader life sciences CRM/regulatory incumbent that competes with RxLogix for IT budget allocation in top pharma.
  • Oracle (Argus Safety): Oracle Argus Safety is the incumbent market leader in pharmacovigilance safety databases used by most large pharma. RxLogix's PV Case Management, PV Signal, and PV Reports modules directly compete against Argus Safety's case processing, signal detection, and reporting capabilities, and RxLogix's platform explicitly supports migration from Argus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

RxLogix Corporation social profiles

Digital presence

RxLogix Corporation compliance and trust

Trust signal

Compliance7 records

RxLogix Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RxLogix Corporation leadership team

Management profile

Number of profiles

Profiles4 records

RxLogix Corporation subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

RxLogix Corporation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RxLogix Corporation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxLogix Corporation

What does RxLogix Corporation do?

RxLogix builds and sells a unified, cloud-native pharmacovigilance (PV) SaaS AI Platform and related individual modules (PV Case Management, PV Signal, PV Reports, PV Publisher, PV Risk Manager, PV Central, PV Quality) for case intake and processing, signal detection, regulatory reporting, and compliance monitoring across the drug-safety lifecycle. Revenue is generated through subscription licensing of the platform and modules, complemented by professional services (Rapid PV Systems Implementation, PV Strategy, Analytics, Education, Global PV BPO) and managed services for cloud hosting, support, and inspection readiness.

Is RxLogix Corporation a public or private company?

RxLogix Corporation is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RxLogix Corporation founded?

RxLogix Corporation was founded in 2010. It employs 251 to 500 people.

Where is RxLogix Corporation based?

RxLogix Corporation is headquartered in Aventura, United States, in the North America region.

How does RxLogix Corporation make money?

Three revenue lines are on record. SaaS Platform Licensing is the primary driver. The others are professional Services and managed Services.

Who are RxLogix Corporation's main competitors?

Broad incumbents on record are Parexel International, IQVIA and Cognizant Life Sciences (PV Services). Emerging players are AB Cube, EXTEDO and Ennov. Direct peers are Sarjen Systems, ArisGlobal, Veeva Systems and Oracle (Argus Safety).

Does RxLogix Corporation have an API?

Yes. RxLogix offers Open API Connectivity enabling integration with Argus, Aris Global, Salesforce, Medidata, Veeva, and other third-party systems. The API-based architecture supports REST APIs for connectivity with CTMS, EDC, and partner systems.

What industry is RxLogix Corporation in?

RxLogix Corporation's product category is Pharmacovigilance Software. Its primary akta.pro industry code is HLAGALAJ, PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited), with a secondary code of HLAGAKAH, Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswirePharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogixResearchAndMarkets.com has released its 'Pharmacovigilance and Drug Safety Software Market Report 2026,' covering market size, growth projections, and competitive landscape across 16 geographies. The global market is projected to grow from $2.53 billion in 2025 to $2.86 billion in 2026 and reach $4.6 billion by 2030, driven by increasing adverse drug reaction reporting, safety regulations, AI-driven signal detection, and personalized medicine adoption. Notable strategic moves in the sector include Qinecsa's acquisition of Insife ApS in April 2024, while North America led the market in 2025 with Asia-Pacific forecasted to grow swiftly.GlobeNewswirePharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogixResearchAndMarkets.com published its "Pharmacovigilance and Drug Safety Software Market Report 2026," projecting the market to grow from $2.53 billion in 2025 to $2.86 billion in 2026 and reach $4.6 billion by 2030, with a CAGR of 12.6%. The growth is driven by increasing adverse drug reaction reporting, globalization of clinical trials, stringent safety regulations, and advances in AI-driven signal detection. Strategic acquisitions such as Qinecsa's purchase of Insife ApS in April 2024 and product launches like Thermo Fisher Scientific's CorEvidence platform are shaping the competitive landscape.YahooPharmacovigilance and Drug Safety Software Market Report 2026 Featuring Profiles of IQVIA, Oracle Corporation, ArisGlobal, and RXLogixResearchAndMarkets.com has released its Pharmacovigilance and Drug Safety Software Market Report 2026, covering market sizing, competitive landscape, and growth projections for the sector. The market is valued at $2.86 billion in 2026 and projected to reach $4.6 billion by 2030, growing at a CAGR of 12.6%, driven by increasing adverse drug reaction reporting, stringent safety regulations, and expanding post-marketing surveillance needs. The report identifies leading companies including IQVIA, Oracle Corporation, ArisGlobal, and RXLogix, and notes strategic activity such as Qinecsa's acquisition of Insife ApS in April 2024 and Thermo Fisher Scientific's launch of the CorEvidence platform.EIN PresswireRxLogix Launches PVOne.AI, Fourth-Generation Agentic AI Solution for Monitoring Drug Safety and Tracking Adverse EventsRxLogix launched PVOne.AI, a fourth-generation agentic AI solution for pharmacovigilance. The system claims up to 80% reduction in manual effort, 75% higher reviewer productivity, and 50% fewer false positives. It integrates with existing RxLogix platforms and is designed for regulated safety operations.